Squamous cell granulomas of the neck: Histologic regression of metastatic squamous cell carcinoma following chemotherapy and/or radiotherapy

Head and Neck

Volumn 20, Issue 6, 1998, Pages 515-521

  Westra, William H ^a,b   Forastiere, Arlene A ^b   Eisele, David W ^b   Lee, Ding Jen ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cervical lymph nodes; Chemotherapy; Foreign body giant cell; Granuloma; Keratin; Radiotherapy; Squamous cell carcinoma; Tumor regression

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; TIRAPAZAMINE;

ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; FOREIGN BODY REACTION; GRANULOMA; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; NECK DISSECTION; NECK TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CULTURE TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROSIS; FLUOROURACIL; GRANULOMA, FOREIGN-BODY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NECK DISSECTION; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY, ADJUVANT; REGISTRIES; REMISSION INDUCTION; TRIAZINES;

EID: 0031829296     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199809)20:6<515::AID-HED5>3.0.CO;2-J     Document Type: Article

References (17)

1. Spaulding MB, Fischer SG, Wolf GT. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 1994;12:1592-1599.
2. Tavorath R, Pfister DG. Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer. Curr Opin Oncol 1995;7:242-247.
3. Koch WM, Lee DJ, Eisele DW, et al. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otalyrngol Head Neck Surg 1995;121:974-980.
4. Ho CM, Lam KH, Wei WI, Lam LK, Yuen PW. Recurrence of laryngeal or hypopharyngeal primary tumor after radical neck dissection for postradiotherapy neck nodal metastases. Head Neck 1994;16:555-558.
5. Snow GB, Patel P, Leemans CR, Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 1992;249:187-194.
6. Bartelink H, Breur K, Hart G. Radiotherapy of lymph node metastases in patients with squamous cell carcinoma of the head and neck region. Int J Radiat Oncol Biol Phys 1982;8:983-989.
7. Armstrong J, Pfister D, Strong E, et al. The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1996;26: 759-765.
8. Bataini JP, Bernier J, Jaulerry C, Brunin F, Pontvert D, Lave C. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Radiat Oncol Biol Phys 1987;13:817-824.
9. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-939.
10. Al-kourainy K, Kish J, Ensley J, et al. Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 1987;59:233-238.
11. Braun OM, Neumeister B, Popp W, et al. Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy. Cancer 1989;63:1097-1100.
12. Sur M, Sur R, Cooper K, Levin V, Bizos D, Dubazana N. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy. Cancer 1996;77:2200-2205.
13. Shapshay SM, Hong WK, Incze JS, et al. Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma. Am J Surg 1978;136:534-538.
14. Sulfaro S, Frustaci S, Volpe R, et al. A pathologic assessment of tumor residue and stromal changes after intrarterial chemotherapy for head and neck carcinomas. Cancer 1989;64:994-1001.
15. Kellokumpu-Lehtinen P, Soderstrom KO, Kortekangas A, Nordman E. Radiation-induced morphological changes and radiocurability in squamous cell carcinoma of the head and neck region: a preliminary report. Acta Oncol 1990;29:517-520.
16. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Handbook for staging of cancer. Philadelphia: J.B. Lippincott Company, 1993.
17. Sundstrom BE, Stigbrand TI. Cytokeratins and tissue polypeptide antigen. Int J Biol Markers 1994;9:102-108.